Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform technology. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2007-07-10. The company specializes in stabilizing carbohydrate molecules. The company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two advanced programs are the cosmetic skin lightener and diabetes drug. Other projects include the development of an anti-aging / cell protection library, a novel anti-wrinkle compound, and the launch of an anti-viral program. Its TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. The company is focused on three antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its subsidiary is TFChem S.A.R.L.
Follow-Up Questions
Qui est le CEO de Sirona Biochem Corp ?
Dr. Howard Y est le Chairman of the Board de Sirona Biochem Corp, il a rejoint l'entreprise depuis 2020.
Quelle est la performance du prix de l'action SRBCF ?
Le prix actuel de SRBCF est de $0.0103, il a decreased de 0% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de Sirona Biochem Corp ?
Sirona Biochem Corp appartient à l'industrie Biotechnology et le secteur est Health Care
Quel est la capitalisation boursière de Sirona Biochem Corp ?
La capitalisation boursière actuelle de Sirona Biochem Corp est de $0
Est-ce que Sirona Biochem Corp est un achat, une vente ou un maintien ?
Selon les analystes de Wall Street, 3 analystes ont établi des notations d'analystes pour Sirona Biochem Corp, y compris 3 achat fort, 5 achat, 1 maintien, 0 vente et 3 vente forte
